Santosh Kesari, MD, neuro-oncologist and chair of the department of translational neurosciences, explains why people with MS appear to have a greater risk for cancer.
A new DNA analysis test may help those with persistent urinary tract infections. Learn more from Jennifer Linehan, MD, associate professor of urology and urologic oncology, in an article by the Washington Post.
If you’re experiencing an incessant pain in your left lower abdomen, it can be due to a variety of issues, some of which are more common than others. Learn 6 possible reasons your lower left side is aching from Anton Bilchik, MD, PhD, professor of surgery and chief of gastrointestinal research.
Jennifer Linehan, MD, associate professor of urology and urologic oncology, explains if AZO Urinary Tract Defense®, is a safe over the counter treatment for urinary tract infections.
A 17-year-old teen is left with severe injuries after his vape pen exploded in his mouth. Osita Onugha, MD, MBA, Assistant Professor of Minimally Invasive Chest Surgery and Thoracic Surgical Oncology, weighs in on the dangers of vaping and explain why vaping is harmful to your lungs.
Marlon Garzo Saria, PhD, RN, AOCNS, FAAS, Director of Neuroscience Quality and Outcomes Research, explains the importance of growing the neuro-oncology nursing subspecialty if we want to be able to navigate and take care of patients with CNS tumors. Watch his video interview from the Oncology Nurse Advisor Navigation Summit to learn more.
Garni Barkhoudarian, MD, FAANS, Associate Professor of Neuroscience & Neurosurgery, is one of the experts who comments on this dangerous case. Doctors say a 15-year-old boys is truly lucky to be alive after a knife impales his face and goes into his brain.
Our experts shared the 50 subtle health symptoms you should never ignore. Learn what they are, and how to recognize near-silent symptoms in time to prevent potentially-serious sicknesses.
Biothera Pharmaceuticals Presented Clinical Data from Phase 2 Study Evaluating the Combination of Imprime PGG and Merck’s KEYTRUDA in Triple Negative Breast Cancer at 2019 ASCO Annual Meeting
Steven O’Day, MD, Executive Director of the Saint John’s Cancer Institute and Cancer Clinic at Providence Saint John’s Health Center, and Director of Providence Los Angeles Regional Research, is the principal investigator for a phase 2 triple negative breast cancer study in collaboration with Biothera Pharmaceuticals. Click here to view the findings of the study and download the poster pretension.
Researchers say an unhealthy diet can increase your risk of developing a variety of cancers. Learn about the mistakes we make with our diet and potental solutions from Anton Bilchik, MD, Director of Gastrointestinal & Hepatobiliary Tumors.